Maged Shenouda
Director of Finance/CFO at RELMADA THERAPEUTICS, INC.
Net worth: 162 299 $ as of 2024-03-30
Profile
Maged S.
Shenouda is currently the Chief Financial Officer at Relmada Therapeutics, Inc. He previously worked as a Director at Protea Biosciences, Inc. and Protea Biosciences Group, Inc. He also served as a Managing Director at Blueprint Life Science Group and Stifel, Nicolaus & Co., Inc. Maged has experience as an Analyst at Bear, Stearns & Co., Inc., UBS Securities LLC, and JPMorgan Securities LLC.
He has also worked as a Principal at Abbott Laboratories and as a Management Consultant at Pricewaterhouse & Co. Additionally, Maged held positions as a Senior VP, Head-Business Development & Licensing at Travere Therapeutics, Inc., Chief Financial & Accounting Officer at First Wave Biopharma, Inc., and Head-Business Development & Licensing at Retrophin, Inc. Maged completed his undergraduate studies at St. John's University and holds an MBA from Rutgers Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
RELMADA THERAPEUTICS INC
0.12% | 2024-01-30 | 34,903 ( 0.12% ) | 162 299 $ | 2024-03-30 |
Maged Shenouda active positions
Companies | Position | Start |
---|---|---|
RELMADA THERAPEUTICS, INC. | Director of Finance/CFO | 2020-01-08 |
Former positions of Maged Shenouda
Companies | Position | End |
---|---|---|
FIRST WAVE BIOPHARMA, INC. | Director of Finance/CFO | 2019-11-30 |
PROTEA BIOSCIENCES GROUP, INC | Director/Board Member | 2017-06-08 |
TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | 2014-10-31 |
Blueprint Life Science Group | Corporate Officer/Principal | 2013-08-31 |
Training of Maged Shenouda
St. John's University | Undergraduate Degree |
Rutgers Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ABBOTT LABORATORIES | Health Technology |
TRAVERE THERAPEUTICS, INC. | Health Technology |
FIRST WAVE BIOPHARMA, INC. | Health Technology |
RELMADA THERAPEUTICS, INC. | Health Technology |
Private companies | 9 |
---|---|
Bear, Stearns & Co., Inc.
Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Bear, Stearns & Co., Inc. is a global investment banking, securities trading and brokerage firm located in New York City with additional offices in Dallas, Boston and San Francisco. The firm is a subsidiary Bear Sterns Cos., Inc. (NYSE: BSC). Their equity research team consists of senior analysts located throughout the world. In addition to domestic coverage, they have research teams focusing on Latin America, Asia and Europe. The analysts use a bottom-up approach to stock selection. The Bear Stearns fixed-income research department provides coverage of every sector of the fixed-income universe. The financial analytics and structured transactions group (F.A.S.T) provides investment research, fixed-income portfolio management and analytical systems, trading technology and general financial expertise. The group also provides a broad range of services to financial institutions including asset-liability management, balance sheet restructuring, receivables-based financing analysis, security and portfolio analysis, peer analysis, and historical and real-time market-based information. | Finance |
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Finance |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Protea Biosciences, Inc.
Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Protea Biosciences, Inc. develops technology for micro fluidic protein separation and detection. The firm develops new technology for the identification, characterization, and quantization of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications. the company was founded by Steve Turner in 2001 and is headquartered in Morgantown, WV. | Health Technology |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Finance |
Pricewaterhouse & Co. | Commercial Services |
Salomon Smith Barney | Finance |
Protea Biosciences Group, Inc.
Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
Blueprint Life Science Group |
- Stock Market
- Insiders
- Maged Shenouda